Vitamin E, atherosclerosis prevention

Cambridge Heart Antioxidant Study DATATOR Deprenyl and Tocopherol Antioxidative Therapy of Rarkinsonism FMC, Finnish Mobile Clinic Health Examination Survey GISSI, Gruppo Italiano Studio Soprawivenza Infarto HOPE, Heart Outcome Prevention Evaluation HPFS, Health Professional Follow-up Study NHS, Nurses Health Study PPR Primary Prevention Project SPACE, Secondary Prevention with Antioxidants of Cardiovascular disease in End-stage renal disease VEAPS, Vitamin E Atherosclerosis Prevention Study VECAT Vitamin E Cataract Age-related maculopathy Trial. 

Hodis HN, Mack WJ, LaBree L, et al. Alpha-tocopherol supplementation in healthy individuals reduces low-density lipoprotein oxidation but not atherosclerosis. The Vitamin E Atherosclerosis Prevention Study (VEAPS). Circulation 2002 106 1453-1459. 

Hodis, H.N., Mack, W.J., LaBree, L., Mahrer, ER., Sevanian, A., Liu, C.R., Liu, C.H., Hwang, J., Selzer, R.H., and Azen, S.R, Alpha-tocopherol supplementation in healthy individuals reduces low-density lipoprotein oxidation but not atherosclerosis the Vitamin E Atherosclerosis Prevention Study (VEAPS), Circulation 106 (12), 1453-1459, 2002. 

---